跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
PMS-FLUTICASONE HFA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
PMS-FLUTICASONE HFA
Authorized
STANDARD
PMS-FLUTICASONE HFA
Pharmascience Inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
8ef9f4e9f6fc00ac
Company
Pharmascience Inc
Type
Standard
Approval Details
Approval Id
8ef9f4e9f6fc00ac
Drug Approval Canada Name
PMS-FLUTICASONE HFA
Product Name
PMS-FLUTICASONE HFA
Status
Marketed
Status Date
2022-04-18
Original Market Date
2022-04-18
Din
02503123
Drug Class
Human
Dosage Form
Metered-Dose Aerosol
Route Of Administration
Oral , Inhalation
Schedule
Prescription
Ahfs
68:04.00
Atc Original
R03BA05 FLUTICASONE
Atc Name
r 03 ba 05
Aig Number
0124685004
Company Name
Pharmascience Inc
Company Address
100, 6111 Royalmount Ave, Montreal, Quebec, Canada, H4P 2T4
Company Detail Path
/organization/pharmascience-inc
Company Information
Pharmaceutical Company Name
Pharmascience Inc
Country Name
Canada
Province Name
Quebec
City Name
montréal,quebec,country_ca
Address
6111 av Royalmount bureau 100
Active Ingredients
FLUTICASONE PROPIONATE
125 MCG / ACT
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
8ef9f4e9f6fc00ac
Type
Standard
Back to Health Canada Approvals